Navigation Links
Flextronics Completes Acquisition of Avail

SINGAPORE, Jan. 28 /PRNewswire-FirstCall/ -- Flextronics (Nasdaq: FLEX) today announced that it has completed the previously announced acquisition of Avail Medical Products Inc., a privately-held, market leader in manufacturing disposable medical devices. As a division of the Flextronics Medical segment, Avail will continue to operate as a stand-alone business. Flextronics Medical segment is one of the fastest growing Flextronics segments focused on providing outsourced design, manufacturing and logistics services to the medical device and equipment marketplace, including consumer diagnostic devices, lab and life science equipment, imaging and patient monitoring equipment, hospital beds, and drug delivery devices. With the combination of continued strong organic growth and the acquisition of Avail, Flextronics Medical expects to generate $850-$950 million in revenue in the fiscal year ending March 31, 2009, which represents a year-over-year expected growth rate of 90%.

"The acquisition of Avail expands our existing global design and manufacturing capabilities creating a more robust and competitive offering that now includes a wide range of disposable medical devices such as catheters, wound management and drug delivery devices. The addition of Avail establishes Flextronics as a leading supplier and partner for the medical industry," said Dan Croteau, president, Flextronics Medical. "This is a highly strategic acquisition for Flextronics and I am pleased to welcome the talented Avail staff to our organization."

About Flextronics

Headquartered in Singapore (Singapore Reg. No. 199002645H), Flextronics is a leading Electronics Manufacturing Services (EMS) provider focused on delivering complete design, engineering and manufacturing services to automotive, computing, consumer digital, industrial, infrastructure, medical and mobile OEMs. With the acquisition of Solectron, pro forma fiscal year 2007 revenues from continuing operations are more than US$30.0 billion. Flextronics helps customers design, build, ship, and service electronics products through a network of facilities in 30 countries on four continents. This global presence provides design and engineering solutions that are combined with core electronics manufacturing and logistics services, and vertically integrated with components technologies, to optimize customer operations by lowering costs and reducing time to market. For more information, please visit

This press release contains forward-looking statements. These forward- looking statements include statements related to plans, projections and estimates regarding the acquisition, including future financial and operating results. These forward-looking statements are based on current assumptions and expectations and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. These risks include that the revenues, cost savings, growth prospects and any other synergies expected from the acquisition may not be fully realized due to difficulties integrating the businesses, operations and product lines of Avail or may take longer to realize than expected. The forward-looking statements in this communication are based on current expectations and Flextronics assumes no obligation to update these forward- looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements.

SOURCE Flextronics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Flextronics to Report Third Quarter Results
2. Flextronics Announces Change in Control Repurchase Offer for Solectrons 0.50% Senior Convertible Notes
3. Flextronics Announces Second Quarter Record Results
4. Flextronics Announces Redemption and Change of Control Repurchase Offer for Solectron 8.00% Senior Subordinated Notes and Planned Change of Control Repurchase Offer for Solectrons 0.50% Senior Convertible Notes
5. Flextronics Completes Acquisition of Solectron
6. Flextronics Shareholders and Solectron Stockholders Approve Acquisition
7. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
8. Cardiac Science Completes Deployment of AEDs With Los Angeles County Fire Department
9. Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard
10. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
11. Specialty Blades, Inc. Completes Acquisition of Popper and Sons, Inc.
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions announced ... User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of Dynamics ... software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ...
(Date:11/27/2015)... ... 2015 , ... The men and women on this list ... the country. They have overseen financial turnarounds, shown commitment to their community through ... as a whole through their advocacy and professional efforts. , Becker's Hospital Review ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they also ... buy during the Black Friday and Cyber Monday massage chair sales to ... Internet high and low to find the best massage chair deals, they can see ...
(Date:11/26/2015)... ... 2015 , ... PRMA Plastic Surgery is updating their record books yet again ... free flap breast reconstruction surgery! , “What an accomplishment for the PRMA team, says ... and it’s an honor to have served all of these women.” , PRMA is ...
(Date:11/25/2015)... OAK BROOK, Ill. (PRWEB) , ... November 25, ... ... sometimes larger and potentially more aggressive than those found on mammography, according to ... cases MRI findings of additional cancers not seen on mammography may necessitate a ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... MINNEAPOLIS , Nov. 25, 2015  ARKRAY ... care products, continues to provide evidence demonstrating the accuracy ... the World Congress on Insulin Resistance, Diabetes and Cardiovascular ... showed that both the Company,s GLUCOCARD ® 01 ... met high accuracy requirements. The ability to accurately measure ...
Breaking Medicine Technology: